Scientific Management Committee

The Duke School of Medicine Scientific Management Committee is a diverse group of faculty and research administrators who provide independent review and provide recommendations on research and data integrity for high-risk, high-profile, commercializable or translational science.  This independent review provides a coordinated evaluation of the research with proactive discussion and management across all components of institutional integrity compliance. 

• The Committee Chairs work with faculty, study-specific Data Safety Monitoring Boards (DSMBs), Conflict of Interest Office, Office of Licensing and Ventures (OLV), Office of Research Contracts (ORC), Advancing Scientific Integrity, Services and Training (ASIST), and the Clinical Quality Management Program (CQMP) to communicate and implement Scientific Management Committee recommendations.

Committee Co-Chairs

Geeta K. Swamy, MD

Associate Vice President for Research and Vice Dean for Scientific Integrity

Gregory P. Samsa, PhD

Associate Professor of Biostatistics and Bioinformatics

Director, Conflict of Interest

Lindsey Spangler, JD 

Asst. Dean, Research Facilitation


Committee Members

Gavin Foltz, J.D.

Associate Dean and Executive Director, Office of Research Contracts

William Gottschalk, Ph.D.

Assistant Professor of Neurology

David Kirsch, M.D., Ph.D.

Barbara Levine University Professor, Radiation Oncology

Donald McDonnell, Ph.D

Chair, Department of Pharmacology & Cancer Biology

Susanna Naggie, M.D.

Associate Professor of Medicine

Scott Palmer, M.D.

Professor of Medicine

Carl Pieper, DPH

Associate Professor of Biostatistics and Bioinformatics

Robin Rasor, M.S., C.L.P.

Executive Director, Office of Licensing and Ventures


Angie Solomon

Associate Director, Conflict of Interest


Herman Staats, Ph.D.

Professor of Pathology

William Steinbach, M.D

Professor of Pediatrics

Bruce Sullenger, Ph.D

Joseph W. and Dorothy W. Beard Professor of Experimental Surgery, in the School of Medicine